Louisiana State Employees Retirement System Acquires Shares of 9,900 LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Louisiana State Employees Retirement System acquired a new stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) in the 4th quarter, HoldingsChannel.com reports. The firm acquired 9,900 shares of the medical instruments supplier’s stock, valued at approximately $562,000.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Exchange Traded Concepts LLC lifted its stake in LeMaitre Vascular by 0.8% during the 4th quarter. Exchange Traded Concepts LLC now owns 23,656 shares of the medical instruments supplier’s stock valued at $1,343,000 after acquiring an additional 187 shares during the period. Riverwater Partners LLC lifted its stake in LeMaitre Vascular by 2.5% during the 4th quarter. Riverwater Partners LLC now owns 8,216 shares of the medical instruments supplier’s stock valued at $466,000 after acquiring an additional 198 shares during the period. Swiss National Bank increased its holdings in shares of LeMaitre Vascular by 1.2% during the 3rd quarter. Swiss National Bank now owns 43,900 shares of the medical instruments supplier’s stock valued at $2,392,000 after purchasing an additional 500 shares in the last quarter. Victory Capital Management Inc. increased its holdings in shares of LeMaitre Vascular by 0.7% during the 3rd quarter. Victory Capital Management Inc. now owns 76,915 shares of the medical instruments supplier’s stock valued at $4,190,000 after purchasing an additional 557 shares in the last quarter. Finally, BluePath Capital Management LLC purchased a new position in shares of LeMaitre Vascular during the 3rd quarter valued at approximately $31,000. 84.64% of the stock is currently owned by institutional investors and hedge funds.

LeMaitre Vascular Stock Performance

Shares of NASDAQ LMAT opened at $65.46 on Monday. The firm has a market cap of $1.47 billion, a PE ratio of 48.85, a PEG ratio of 2.82 and a beta of 0.87. The firm has a fifty day moving average of $65.35 and a 200 day moving average of $58.15. LeMaitre Vascular, Inc. has a one year low of $44.27 and a one year high of $74.64.

LeMaitre Vascular (NASDAQ:LMAT) last issued its quarterly earnings results on Tuesday, February 27th. The medical instruments supplier reported $0.38 EPS for the quarter, topping the consensus estimate of $0.36 by $0.02. LeMaitre Vascular had a net margin of 15.56% and a return on equity of 10.57%. The company had revenue of $48.90 million during the quarter, compared to analyst estimates of $49.01 million. During the same quarter in the previous year, the firm earned $0.25 EPS. The firm’s revenue was up 19.3% compared to the same quarter last year. On average, equities analysts predict that LeMaitre Vascular, Inc. will post 1.66 EPS for the current fiscal year.

LeMaitre Vascular Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 28th. Stockholders of record on Thursday, March 14th were issued a dividend of $0.16 per share. This is a positive change from LeMaitre Vascular’s previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Wednesday, March 13th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.98%. LeMaitre Vascular’s dividend payout ratio is presently 47.76%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on LMAT shares. KeyCorp started coverage on shares of LeMaitre Vascular in a report on Tuesday, February 6th. They set a “sector weight” rating for the company. Stifel Nicolaus raised shares of LeMaitre Vascular from a “hold” rating to a “buy” rating and lifted their target price for the company from $59.00 to $75.00 in a report on Friday. StockNews.com lowered shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a report on Tuesday, April 16th. Finally, Barrington Research lifted their target price on shares of LeMaitre Vascular from $66.00 to $69.00 and gave the company an “outperform” rating in a report on Wednesday, February 28th. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $69.33.

Insider Transactions at LeMaitre Vascular

In other news, Director Lawrence J. Jasinski sold 5,110 shares of the company’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $67.50, for a total transaction of $344,925.00. Following the completion of the sale, the director now owns 5,309 shares of the company’s stock, valued at $358,357.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, Director Lawrence J. Jasinski sold 5,110 shares of the business’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $67.50, for a total transaction of $344,925.00. Following the transaction, the director now owns 5,309 shares of the company’s stock, valued at approximately $358,357.50. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Joseph P. Pellegrino, Jr. sold 36,967 shares of the business’s stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $69.76, for a total transaction of $2,578,817.92. Following the transaction, the chief financial officer now directly owns 6,452 shares in the company, valued at approximately $450,091.52. The disclosure for this sale can be found here. Insiders sold 114,036 shares of company stock valued at $7,873,749 over the last 90 days. 10.79% of the stock is currently owned by corporate insiders.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.